Stephen Morlock, Director at BioPharmX Corp (BPMX), bought 3,000 shares at $1.26 ($4K) on 2015-10-09, disclosed to the SEC on 2015-10-13.
Open-market purchase of $4k BPMX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.19 | 2,000 | $2K | 65.4% |
| 2 | $1.26 | 1,000 | $1K | 34.6% |
| Total | $1.21 avg | 3,000 | $4K | 100% |
| Filing → |
| BPMX | BUY | 2016-11-29 | $150K | — | Filing → |
| BPMX | BUY | 2016-01-15 | $18K | — | Filing → |
| BPMX | BUY | 2016-01-12 | $9K | — | Filing → |